Filings

6 documents · 61 matches

1. ALGS Aligos Therapeutics, Inc. 10-Q 2026-08-06

   Item 1A. Risk Factors.

   tariff exemptions. Despite recent court rulings against the legality of certain of the Trump administration’s tariffs, the uncertainty in tariff
   12 matches in this document Show context Copy citation

2. ALGS Aligos Therapeutics, Inc. 10-Q 2026-11-06

   Item 1A. Risk Factors.

   tariff exemptions. Despite recent court rulings against the legality of certain of the Trump administration’s tariffs, the uncertainty in tariff
   13 matches in this document Show context Copy citation

3. ALGS Aligos Therapeutics, Inc. 10-Q 2026-05-07

   Item 1A. Risk Factors.

   tariff exemptions. Despite recent court rulings against the legality of certain of the Trump administration’s tariffs, the uncertainty in tariff
   12 matches in this document Show context Copy citation

4. ALGS Aligos Therapeutics, Inc. 10-K 2026-03-05

   Item 1A. Risk Factors.

   tariffs on imported pharmaceutical products. In response, certain foreign governments have announced or implemented reciprocal or retaliatory tariffs and other
   12 matches in this document Show context Copy citation

5. ALGS Aligos Therapeutics, Inc. 10-Q 2025-11-06

   Item 1A. Risk Factors.

   tariffs on pharmaceutical products. Uncertainty in scope and applicability of new tariffs, as well as the cost of the tariffs
   9 matches in this document Show context Copy citation

6. ALGS Aligos Therapeutics, Inc. 10-Q 2025-08-06

   Item 1A. Risk Factors.

   tariffs will likely result in increased research and development expenses, including with respect to increased costs associated with drug product
   3 matches in this document Show context Copy citation